Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2010

01.12.2010 | Case Report

Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries

verfasst von: Aditi I. Dagli, Philip J. Lee, Catherine E. Correia, Christina Rodriguez, Kaustav Bhattacharya, Linda Steinkrauss, Charles A. Stanley, David A. Weinstein

Erschienen in: Journal of Inherited Metabolic Disease | Sonderheft 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Patients with type Ia glycogen storage disease (GSD) have been surviving well into adulthood since continuous glucose therapy was introduced in the 1970s, and there have been many documented successful pregnancies in women with this condition. Historically, few individuals with type Ib GSD, however, survived into adulthood prior to the introduction of granulocyte colony stimulating factor (G-CSF) in the late 1980s. There are no previously published reports of pregnancies in GSD type Ib. In this case report we describe the course and management of five successful pregnancies in three patients with GSD type Ib. Patient 1 experienced an increase in glucose requirement in all three of her pregnancies, starting from the second trimester onwards. There were no major complications related to neutropenia except for oral ulcers. The infants did well, except for respiratory distress in two of them at birth. Patient 2 used cornstarch to maintain euglycemia, but precise dosing was not part of her regimen, and, hence, an increase in metabolic demands was difficult to demonstrate. She developed a renal calculus and urinary tract infection during her pregnancy and had chronic iron deficiency anemia but no neutropenia. The neonate did well after delivery. Patient 3 had poor follow-up during pregnancy. Increasing glucose requirements, worsening lipid profile, neutropenia associated with multiple infections, and anemia were noted. The newborn infant did well after delivery. In addition to the case reports, the challenges of the usage of G-CSF, the treatment of enterocolitis, and comparisons with the management of GSD Ia are discussed.
Literatur
Zurück zum Zitat Abe T, Azuma H, Watanabe A, Shigekiyo T, Endou S, Pou R, Fukui R, Maeda K, Aono T, Matsumoto T (2000) A patient with cyclic neutropenia complicated by severe persistent neutropenia successfully delivered a healthy baby. Intern Med 39:663–666PubMedCrossRef Abe T, Azuma H, Watanabe A, Shigekiyo T, Endou S, Pou R, Fukui R, Maeda K, Aono T, Matsumoto T (2000) A patient with cyclic neutropenia complicated by severe persistent neutropenia successfully delivered a healthy baby. Intern Med 39:663–666PubMedCrossRef
Zurück zum Zitat Baird DD, Narendranathan M, Sandler RS (1990) Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99:987–994PubMed Baird DD, Narendranathan M, Sandler RS (1990) Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99:987–994PubMed
Zurück zum Zitat Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG (2009) Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis 15:25–28PubMedCrossRef Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG (2009) Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis 15:25–28PubMedCrossRef
Zurück zum Zitat Bhatti S, Parry E (2006) Successful pregnancy in a woman with glycogen storage disease type III. Aust N Z J Obstet Gynaecol 46:168–169PubMedCrossRef Bhatti S, Parry E (2006) Successful pregnancy in a woman with glycogen storage disease type III. Aust N Z J Obstet Gynaecol 46:168–169PubMedCrossRef
Zurück zum Zitat Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M (2007) Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 22:542–549PubMedCrossRef Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M (2007) Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 22:542–549PubMedCrossRef
Zurück zum Zitat Calhoun DA, Rosa C, Christensen RD (1996) Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol 174:1306–1311PubMedCrossRef Calhoun DA, Rosa C, Christensen RD (1996) Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol 174:1306–1311PubMedCrossRef
Zurück zum Zitat Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB (2009) A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 36:635–641PubMedCrossRef Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB (2009) A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 36:635–641PubMedCrossRef
Zurück zum Zitat Coburn LA, Wise PE, Schwartz DA (2006) The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy. Dig Dis Sci 51:2045–2047PubMedCrossRef Coburn LA, Wise PE, Schwartz DA (2006) The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy. Dig Dis Sci 51:2045–2047PubMedCrossRef
Zurück zum Zitat Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, Delcroix M (1994) Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 344:620–621PubMedCrossRef Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, Delcroix M (1994) Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 344:620–621PubMedCrossRef
Zurück zum Zitat Confino E, Pauzner D, Lidor A, Yedwab G, David M (1984) Pregnancy associated with amylo-1,6-glucosidase deficiency (Forbe’s disease). Case report. Br J Obstet Gynaecol 91:494–497PubMedCrossRef Confino E, Pauzner D, Lidor A, Yedwab G, David M (1984) Pregnancy associated with amylo-1,6-glucosidase deficiency (Forbe’s disease). Case report. Br J Obstet Gynaecol 91:494–497PubMedCrossRef
Zurück zum Zitat Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56:830–837PubMedCrossRef Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56:830–837PubMedCrossRef
Zurück zum Zitat Dale DC, Cottle TE, Fier CJ, Bonilla BAA, LA MA B, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K (2003) Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72:82–93PubMedCrossRef Dale DC, Cottle TE, Fier CJ, Bonilla BAA, LA MA B, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K (2003) Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72:82–93PubMedCrossRef
Zurück zum Zitat Davis MK, Rufo PA, Polyak SF, Weinstein DA (2008) Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib. J Inherit Metab Dis [Epub ahead of print] Davis MK, Rufo PA, Polyak SF, Weinstein DA (2008) Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib. J Inherit Metab Dis [Epub ahead of print]
Zurück zum Zitat Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G (1998) The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114:23–28PubMedCrossRef Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G (1998) The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114:23–28PubMedCrossRef
Zurück zum Zitat Farber M, Knuppel RA, Binkiewicz A, Kennison RD (1976) Pregnancy and von Gierke’s disease. Obstet Gynecol 47:226–228PubMed Farber M, Knuppel RA, Binkiewicz A, Kennison RD (1976) Pregnancy and von Gierke’s disease. Obstet Gynecol 47:226–228PubMed
Zurück zum Zitat Fujiwaki R, Hata T, Hata K, Kitao M, Furuya H, Katoh Y (1995) Effective treatment of drug-induced agranulocytosis using recombinant human granulocyte colony stimulating factor in pregnancy. Gynecol Obstet Invest 40:276–277PubMedCrossRef Fujiwaki R, Hata T, Hata K, Kitao M, Furuya H, Katoh Y (1995) Effective treatment of drug-induced agranulocytosis using recombinant human granulocyte colony stimulating factor in pregnancy. Gynecol Obstet Invest 40:276–277PubMedCrossRef
Zurück zum Zitat Fung YL, Pitcher LA, Taylor K, Minchinton RM (2005) Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med 15:151–155PubMedCrossRef Fung YL, Pitcher LA, Taylor K, Minchinton RM (2005) Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med 15:151–155PubMedCrossRef
Zurück zum Zitat Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P (2006) Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 130:323–333PubMedCrossRef Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P (2006) Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 130:323–333PubMedCrossRef
Zurück zum Zitat Hyrich KL, Symmons DP, Watson KD, Silman AJ (2006) Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum 54:2701–2702PubMedCrossRef Hyrich KL, Symmons DP, Watson KD, Silman AJ (2006) Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum 54:2701–2702PubMedCrossRef
Zurück zum Zitat Johnson MP, Compton A, Drugan A, Evans MI (1990) Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 75:507–510PubMed Johnson MP, Compton A, Drugan A, Evans MI (1990) Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 75:507–510PubMed
Zurück zum Zitat Kaufmann SJ, Sharif K, Sharma V, McVerry BA (1998) Term delivery in a woman with severe congenital neutropenia, treated with growth colony stimulating factor. Hum Reprod 13:498–499PubMedCrossRef Kaufmann SJ, Sharif K, Sharma V, McVerry BA (1998) Term delivery in a woman with severe congenital neutropenia, treated with growth colony stimulating factor. Hum Reprod 13:498–499PubMedCrossRef
Zurück zum Zitat Kraemer B, Abele H, Hahn M, Rajab T, Kraemer E, Wallweiner D, Becker S (2008) A successful pregnancy in a patient with Takayasu’s arteritis. Hypertens Pregnancy 27:247–252PubMedCrossRef Kraemer B, Abele H, Hahn M, Rajab T, Kraemer E, Wallweiner D, Becker S (2008) A successful pregnancy in a patient with Takayasu’s arteritis. Hypertens Pregnancy 27:247–252PubMedCrossRef
Zurück zum Zitat Lee P (1999) Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol 106:181–182PubMed Lee P (1999) Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol 106:181–182PubMed
Zurück zum Zitat Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, Sauer PJ, Smit GP (2008) Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 198:646.e1–646.e7CrossRef Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, Sauer PJ, Smit GP (2008) Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 198:646.e1–646.e7CrossRef
Zurück zum Zitat Mishkin DS, Van Deinse W, Becker JM, Farraye FA (2006) Successful use of adalimumab (Humira) for Crohn’s disease in pregnancy. Inflamm Bowel Dis 12:827–828PubMedCrossRef Mishkin DS, Van Deinse W, Becker JM, Farraye FA (2006) Successful use of adalimumab (Humira) for Crohn’s disease in pregnancy. Inflamm Bowel Dis 12:827–828PubMedCrossRef
Zurück zum Zitat Mottet C, Juillerat P, Pittet V, Gonvers JJ, Froehlich F, Vader JP, Michetti P, Felley C (2007) Pregnancy and breastfeeding in patients with Crohn’s disease. Digestion 76:149–160PubMedCrossRef Mottet C, Juillerat P, Pittet V, Gonvers JJ, Froehlich F, Vader JP, Michetti P, Felley C (2007) Pregnancy and breastfeeding in patients with Crohn’s disease. Digestion 76:149–160PubMedCrossRef
Zurück zum Zitat Niedermeier DM, Frei-Lahr DA, Hall PD (2005) Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 25:1134–1140PubMedCrossRef Niedermeier DM, Frei-Lahr DA, Hall PD (2005) Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 25:1134–1140PubMedCrossRef
Zurück zum Zitat Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S (1984) Pregnancy in Crohn’s disease. Scand J Gastroenterol 19:724–732PubMed Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S (1984) Pregnancy in Crohn’s disease. Scand J Gastroenterol 19:724–732PubMed
Zurück zum Zitat Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT (2003) Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 52:243–247PubMedCrossRef Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT (2003) Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 52:243–247PubMedCrossRef
Zurück zum Zitat Norgard B, Pedersen L, Christensen LA, Sorensen HT (2007) Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 102:1406–1413PubMedCrossRef Norgard B, Pedersen L, Christensen LA, Sorensen HT (2007) Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 102:1406–1413PubMedCrossRef
Zurück zum Zitat O’Donnell S, O’Morain C (2008) Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther 27:885–894PubMedCrossRef O’Donnell S, O’Morain C (2008) Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther 27:885–894PubMedCrossRef
Zurück zum Zitat Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L (2007) Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 46:695–698CrossRef Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L (2007) Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 46:695–698CrossRef
Zurück zum Zitat Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke’s disease). Am J Obstet Gynecol 170:1687–1690, discussion 1690–1691PubMed Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke’s disease). Am J Obstet Gynecol 170:1687–1690, discussion 1690–1691PubMed
Zurück zum Zitat Sangalli MR, Peek M, McDonald A (2001) Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy. Aust N Z J Obstet Gynaecol 41:470–471PubMedCrossRef Sangalli MR, Peek M, McDonald A (2001) Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy. Aust N Z J Obstet Gynaecol 41:470–471PubMedCrossRef
Zurück zum Zitat Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN (2000) Management of hepatocellular adenoma during pregnancy. Liver 20:186–187PubMedCrossRef Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN (2000) Management of hepatocellular adenoma during pregnancy. Liver 20:186–187PubMedCrossRef
Zurück zum Zitat Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GP (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 137:187–191PubMedCrossRef Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GP (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 137:187–191PubMedCrossRef
Zurück zum Zitat Weinstein DA, Somers MJ, Wolfsdorf JI (2001) Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 138:378–382PubMedCrossRef Weinstein DA, Somers MJ, Wolfsdorf JI (2001) Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 138:378–382PubMedCrossRef
Zurück zum Zitat Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95–102PubMedCrossRef Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95–102PubMedCrossRef
Zurück zum Zitat Woolfson K, Cohen Z, McLeod RS (1990) Crohn’s disease and pregnancy. Dis Colon Rectum 33:869–873PubMedCrossRef Woolfson K, Cohen Z, McLeod RS (1990) Crohn’s disease and pregnancy. Dis Colon Rectum 33:869–873PubMedCrossRef
Metadaten
Titel
Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries
verfasst von
Aditi I. Dagli
Philip J. Lee
Catherine E. Correia
Christina Rodriguez
Kaustav Bhattacharya
Linda Steinkrauss
Charles A. Stanley
David A. Weinstein
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe Sonderheft 3/2010
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9054-1

Weitere Artikel der Sonderheft 3/2010

Journal of Inherited Metabolic Disease 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.